0

506128

PARNAXLAB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

PARNAX LAB LTD. Share Price Today

Investment Returns

Over 1 Month -10.57% Over 3 Months 18.96% Over 6 Months 9.02% Over 1 Year 35.76%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

PARNAX LAB LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 157.40
  • P/E Ratio (TTM) 177.99
  • Beta 0.93
  • Book Value / share 20.38
  • Return on equity 5.00%
  • EPS (TTM) 0.80
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -0.55
info icon alternate text

PARNAX LAB LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 0.25
Operating Expense 3.28
Net Profit -0.55
Net Profit Margin (%) -220.00
Earnings Per Share (EPS) -0.48
EBITDA -1.25
Effective Tax Rate (%) 57.03
Particulars DEC 2025 (Values in Cr)
Revenue 2.71
Operating Expense 1.95
Net Profit 0.71
Net Profit Margin (%) 26.19
Earnings Per Share (EPS) 0.62
EBITDA 0.97
Effective Tax Rate (%) 25.26
Particulars SEP 2025 (Values in Cr)
Revenue 1.70
Operating Expense 1.24
Net Profit 0.49
Net Profit Margin (%) 28.82
Earnings Per Share (EPS) 0.43
EBITDA 0.70
Effective Tax Rate (%) 25.75
Particulars JUN 2025 (Values in Cr)
Revenue 1.97
Operating Expense 1.84
Net Profit 0.23
Net Profit Margin (%) 11.67
Earnings Per Share (EPS) 0.20
EBITDA 0.34
Effective Tax Rate (%) 25.80
Particulars MAR 2025 (Values in Cr)
Revenue 0.84
Operating Expense 1.14
Net Profit -0.08
Net Profit Margin (%) -9.52
Earnings Per Share (EPS) -0.07
EBITDA -0.08
Effective Tax Rate (%) 27.27
Particulars MAR 2026 (Values in Cr)
Revenue 6.63
Operating Expense 8.30
Net Profit 0.89
Net Profit Margin (%) 13.42
Earnings Per Share (EPS) 0.77
EBITDA 0.74
Effective Tax Rate (%) -36.92
Particulars MAR 2025 (Values in Cr)
Revenue 7.02
Operating Expense 5.86
Net Profit 1.39
Net Profit Margin (%) 19.80
Earnings Per Share (EPS) 1.21
EBITDA 1.94
Effective Tax Rate (%) 24.73
Particulars MAR 2024 (Values in Cr)
Revenue 7.44
Operating Expense 5.52
Net Profit 1.82
Net Profit Margin (%) 24.46
Earnings Per Share (EPS) 1.59
EBITDA 2.65
Effective Tax Rate (%) 25.30
Particulars MAR 2023 (Values in Cr)
Revenue 7.47
Operating Expense 6.22
Net Profit 1.20
Net Profit Margin (%) 16.06
Earnings Per Share (EPS) 1.09
EBITDA 1.95
Effective Tax Rate (%) 25.76
Particulars MAR 2022 (Values in Cr)
Revenue 7.15
Operating Expense 6.54
Net Profit 0.54
Net Profit Margin (%) 7.55
Earnings Per Share (EPS) 0.64
EBITDA 1.53
Effective Tax Rate (%) 30.76
Particulars MAR 2025 (Values in Cr)
Book Value / Share 72.35
ROE % 14.92
ROCE % 13.77
Total Debt to Total Equity 0.97
EBITDA Margin 15.15
Particulars MAR 2024 (Values in Cr)
Book Value / Share 62.32
ROE % 14.39
ROCE % 12.87
Total Debt to Total Equity 1.01
EBITDA Margin 12.91
Particulars MAR 2023 (Values in Cr)
Book Value / Share 54.11
ROE % 15.64
ROCE % 14.66
Total Debt to Total Equity 1.12
EBITDA Margin 14.18
Particulars MAR 2022 (Values in Cr)
Book Value / Share 47.24
ROE % 20.47
ROCE % 16.71
Total Debt to Total Equity 1.59
EBITDA Margin 14.33
Particulars MAR 2021 (Values in Cr)
Book Value / Share 38.26
ROE % -1.13
ROCE % 5.67
Total Debt to Total Equity 1.69
EBITDA Margin 11.27
Particulars MAR 2025 (Values in Cr)
Book Value / Share 19.63
ROE % 5.00
ROCE % 6.72
Total Debt to Total Equity 0.00
EBITDA Margin 27.64
Particulars MAR 2024 (Values in Cr)
Book Value / Share 18.42
ROE % 6.54
ROCE % 9.09
Total Debt to Total Equity 0.03
EBITDA Margin 35.62
Particulars MAR 2023 (Values in Cr)
Book Value / Share 16.85
ROE % 4.77
ROCE % 6.18
Total Debt to Total Equity 0.32
EBITDA Margin 25.97
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.14
ROE % 3.98
ROCE % 6.24
Total Debt to Total Equity 1.18
EBITDA Margin 21.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 5.54
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.13
EBITDA Margin -16.03
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.68
Total Assets 189.81
Total Liabilities 189.81
Total Equity 83.24
Share Outstanding 1
Price to Book Ratio 5.45
Return on Assets (%) 6.06
Return on Capital (%) 8.01
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.87
Total Assets 190.26
Total Liabilities 190.26
Total Equity 71.69
Share Outstanding 1
Price to Book Ratio 7.03
Return on Assets (%) 5.05
Return on Capital (%) 6.73
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.78
Total Assets 145.07
Total Liabilities 145.07
Total Equity 62.26
Share Outstanding 1
Price to Book Ratio 3.09
Return on Assets (%) 5.94
Return on Capital (%) 7.62
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.78
Total Assets 153.46
Total Liabilities 153.46
Total Equity 48.27
Share Outstanding 0
Price to Book Ratio 11.82
Return on Assets (%) 5.37
Return on Capital (%) 7.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.26
Total Assets 106.25
Total Liabilities 106.25
Total Equity 32.62
Share Outstanding 0
Price to Book Ratio 3.52
Return on Assets (%) -0.34
Return on Capital (%) -0.41
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.27
Total Assets 24.71
Total Liabilities 24.71
Total Equity 22.54
Share Outstanding 1
Price to Book Ratio 5.45
Return on Assets (%) 5.64
Return on Capital (%) 6.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.45
Total Assets 22.23
Total Liabilities 22.23
Total Equity 21.15
Share Outstanding 1
Price to Book Ratio 7.03
Return on Assets (%) 8.20
Return on Capital (%) 8.62
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.28
Total Assets 21.36
Total Liabilities 21.36
Total Equity 19.35
Share Outstanding 1
Price to Book Ratio 3.09
Return on Assets (%) 5.63
Return on Capital (%) 5.9
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.34
Total Assets 23.53
Total Liabilities 23.53
Total Equity 12.74
Share Outstanding 0
Price to Book Ratio 11.82
Return on Assets (%) 2.30
Return on Capital (%) 2.47
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 17.64
Total Liabilities 17.64
Total Equity 4.71
Share Outstanding 0
Price to Book Ratio 3.52
Return on Assets (%) -6.41
Return on Capital (%) -7.02
Particulars MAR 2025 (Values in Cr)
Net Income 15.67
Cash from Operations 35.04
Cash from Investing -16.39
Cash from Financing -15.81
Net change in Cash 0.09
Free Cash Flow 44.79
Particulars MAR 2024 (Values in Cr)
Net Income 12.04
Cash from Operations 18.51
Cash from Investing -31.51
Cash from Financing 14.81
Net change in Cash -0.82
Free Cash Flow 32.65
Particulars MAR 2023 (Values in Cr)
Net Income 12.27
Cash from Operations 23.77
Cash from Investing -9.92
Cash from Financing -14.06
Net change in Cash -3.08
Free Cash Flow 35.05
Particulars MAR 2022 (Values in Cr)
Net Income 12.26
Cash from Operations 8.78
Cash from Investing -16.49
Cash from Financing 12.13
Net change in Cash 4.18
Free Cash Flow 26.61
Particulars MAR 2021 (Values in Cr)
Net Income -0.08
Cash from Operations 7.06
Cash from Investing -6.56
Cash from Financing 0.05
Net change in Cash -0.20
Free Cash Flow 11.61
Particulars MAR 2025 (Values in Cr)
Net Income 1.85
Cash from Operations 0.30
Cash from Investing -0.19
Cash from Financing -0.02
Net change in Cash 0.06
Free Cash Flow 0.30
Particulars MAR 2024 (Values in Cr)
Net Income 2.44
Cash from Operations 0.09
Cash from Investing 0.30
Cash from Financing -1.21
Net change in Cash -0.82
Free Cash Flow 0.21
Particulars MAR 2023 (Values in Cr)
Net Income 1.62
Cash from Operations -0.26
Cash from Investing 0.13
Cash from Financing -2.92
Net change in Cash -3.06
Free Cash Flow -0.21
Particulars MAR 2022 (Values in Cr)
Net Income 0.77
Cash from Operations -0.35
Cash from Investing 0.00
Cash from Financing 4.59
Net change in Cash 4.23
Free Cash Flow -0.35
Particulars MAR 2021 (Values in Cr)
Net Income -1.25
Cash from Operations 0.47
Cash from Investing 0.00
Cash from Financing -0.47
Net change in Cash 0.00
Free Cash Flow 0.47
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.14 1.53 243.69 23.12 38.85
BLISS GVS PHARMA LTD. 486.60 39.50 4.32 5160.70 118.35 493.70
CIPLA LTD 1353.85 28.73 3.17 109370.14 1165.55 1672.20
FERMENTA BIOTECH LIMITED 338.20 14.92 2.44 995.36 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 546.70 24.50 4.26 1580.54 490.00 789.95
ASTRAZENECA PHARMA IND LT 8406.60 109.79 24.07 21016.50 7630.00 9850.00
BLISS GVS PHARMA LTD. 486.60 52.49 4.46 5160.70 118.35 493.70

PARNAX LAB LTD. shareholding pattern

Holding
27.7%
72.29%
9.41%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

PARNAX LAB LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
137.05 2.23 redarrow
red-green-graph indicator
5 Bearish
11 Bullish
  • 5 Days 134.60
  • 26 Days 137.90
  • 10 Days 133.80
  • 50 Days 140.10
  • 12 Days 134.10
  • 100 Days 137.40
  • 20 Days 136.30
  • 200 Days 132.50
135.35 PIVOT
First Support 132.25 First Resistance 137.15 Second Support 130.45 Second Resistance 140.25 Third Support 127.35 Third Resistance 142.05
RSI 48.79 ADX 36.90 MACD -3.83 Williams % R -9.18 Commodity Channel Index (CCI) 9.52
Date 2026-06-19 Week 3793.00 Same Day 1648.00 Month 5530.00
1 Year 0.94 3 Year 0.72
Over 1 Month
-10.57% down
Over 1 Year
35.76% down
Over 3 Months
18.96% down
Over 3 Years
29.29% down
Over 6 Months
9.02% down
Over 5 Years
38.44% down

PARNAX LAB LTD. Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Parnax Lab Ltd?

Answer Field

Parnax Lab Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 137.05 as on Jun 19 2026 03:28 PM.

What is the Market Cap of Parnax Lab Ltd Share?

Answer Field

The market cap of Parnax Lab Ltd for NSE ₹ 0.00 & for BSE ₹ 157.40 as on Jun 19 2026 03:28 PM.

What is the 52 Week High and Low of Parnax Lab Ltd?

Answer Field

The 52 Week High and Low of Parnax Lab Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 182.00 and ₹ 96.25.

What is 1 year return for Parnax Lab Ltd?

Answer Field

The 1 year returns on the stock has been 35.76%.

What is the P/E Ratio of Parnax Lab Ltd Share?

Answer Field

As on Jun 19 2026 03:28 PM the price-to-earnings (PE) ratio for Parnax Lab Ltd share is 177.99.

What is the PB ratio of Parnax Lab Ltd Share?

Answer Field

As on Jun 19 2026 03:28 PM, the price-to-book (PB) ratio for Parnax Lab Ltd share is 20.38.

How to Buy Parnax Lab Ltd Share?

Answer Field

You can trade in Parnax Lab Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Parnax Lab Ltd Share on Bajaj Broking App?

Answer Field

To buy Parnax Lab Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Parnax Lab Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|